Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|July 1, 1995
Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinomaJ E Ferguson, P Hulse, P Lorigan, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiationJ Prendiville, P Lorigan, F Hicks, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 6, 2014
Assessing the impact of diagnosis and the related supportive care needs in patients with cutaneous melanomaZoe Stamataki, L Brunton, P Lorigan, et al.ESMO Open|January 30, 2021
A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS studyF Gomes, P Lorigan, S Woolley, et al.Cytometry|July 13, 2002
Monitoring tumour cells in the peripheral blood of small cell lung cancer patientsB Y Kularatne, P Lorigan, S Browne, et al.British Journal of Cancer|March 29, 2000
A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaM R Middleton, P Lorigan, J Owen, et al.European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancerS Baka, M Ranson, P Lorigan, et al.Lung Cancer (Amsterdam, Netherlands)|August 5, 2008
Radiotherapy for small-cell lung cancer-Where are we heading?N A Bayman, H Sheikh, B Kularatne, et al.Leukemia & Lymphoma|July 1, 1995
MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapyM C Finnegan, J Royds, J R Goepel, et al.Seminars in Oncology|June 1, 1995
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancerP Lorigan, S M Lee, D Betticher, et al.Pageof 7